Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Agenus Inc (NASDAQ: AGEN) was $12.12 for the day, down -5.02% from the previous closing price of $12.76. In other words, the price has decreased by -$5.02 from its previous closing price. On the day, 1.18 million shares were traded. AGEN stock price reached its highest trading level at $12.63 during the session, while it also had its lowest trading level at $11.05.
Ratios:
Our analysis of AGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 06, 2023, initiated with a Outperform rating and assigned the stock a target price of $8.
On June 06, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $80.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 15 ’24 when ARMEN GARO H bought 500,000 shares for $0.65 per share. The transaction valued at 324,050 led to the insider holds 625,969 shares of the business.
WIINBERG ULF bought 25,000 shares of AGEN for $19,000 on Nov 15 ’23. The Director now owns 124,063 shares after completing the transaction at $0.76 per share. On Oct 16 ’23, another insider, AGENUS INC, who serves as the 10% Owner of the company, bought 429 shares for $1.10 each. As a result, the insider paid 472 and bolstered with 21,772,863 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGEN now has a Market Capitalization of 253865520 and an Enterprise Value of 282892576. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.62. Its current Enterprise Value per Revenue stands at 1.81 whereas that against EBITDA is -1.931.
Stock Price History:
The Beta on a monthly basis for AGEN is 1.25, which has changed by -0.5932886 over the last 52 weeks, in comparison to a change of 0.23099434 over the same period for the S&P500. Over the past 52 weeks, AGEN has reached a high of $42.60, while it has fallen to a 52-week low of $4.78. The 50-Day Moving Average of the stock is 10.55%, while the 200-Day Moving Average is calculated to be -31.55%.
Shares Statistics:
AGEN traded an average of 759.71K shares per day over the past three months and 1685070 shares per day over the past ten days. A total of 20.95M shares are outstanding, with a floating share count of 19.91M. Insiders hold about 4.95% of the company’s shares, while institutions hold 54.20% stake in the company. Shares short for AGEN as of 1713139200 were 2587034 with a Short Ratio of 3.41, compared to 1710460800 on 2287283. Therefore, it implies a Short% of Shares Outstanding of 2587034 and a Short% of Float of 12.45.
Earnings Estimates
The market rating of Agenus Inc (AGEN) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.On average, analysts expect EPS of -$2.83 for the current quarter, with a high estimate of -$1.6 and a low estimate of -$4.2, while EPS last year was -$4.4. The consensus estimate for the next quarter is -$2.71, with high estimates of -$1.8 and low estimates of -$4.13.
Analysts are recommending an EPS of between $6.4 and -$17.02 for the fiscal current year, implying an average EPS of -$6.1. EPS for the following year is -$12.91, with 5.0 analysts recommending between -$7.42 and -$21.55.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $46.3M to a low estimate of $34M. As of the current estimate, Agenus Inc’s year-ago sales were $22.9MFor the next quarter, 3 analysts are estimating revenue of $66.56M. There is a high estimate of $148.36M for the next quarter, whereas the lowest estimate is $34M.
A total of 3 analysts have provided revenue estimates for AGEN’s current fiscal year. The highest revenue estimate was $186.24M, while the lowest revenue estimate was $135.8M, resulting in an average revenue estimate of $157.35M. In the same quarter a year ago, actual revenue was $156.31MBased on 5 analysts’ estimates, the company’s revenue will be $199.22M in the next fiscal year. The high estimate is $251.5M and the low estimate is $144.4M.
